| Name | Title | Contact Details |
|---|
MSI Methylation Sciences Inc. (“MSI”) is a clinical-stage pharmaceutical company focused on developing new products based on molecules which have clinical proof of concept but which have yet to be exploited in the major pharmaceutical markets. MSI`s focus is in the CNS space where clinical proof of concept is key to reducing the drug development risk. Our lead product candidate, Strada™, is based upon Ademetionine, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle. Our disease indication is Major Depressive Disorder (MDD).
Allion Healthcare, Inc. is a provider of specialty pharmacy and disease management services focused on Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS) patients, as well as specialized biopharmaceutical medications and services
Health Benchmarks Inc is a Woodland Hills, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
SecureChart is a Baton Rouge, LA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
omnipath diagnostics is a Canoga Park, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.